LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.41 | 27.76 | 1611 | 3105 | 0.5187 | 0.8161 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.41 | 27.76 | 1652 | 3105 | 0.5319 | 0.8228 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.41 | 27.76 | 1950 | 3105 | 0.6279 | 0.8678 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 39.41 | 27.76 | 1976 | 3105 | 0.6363 | 0.8715 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.11 | 27.76 | 1646 | 3331 | 0.4941 | 0.8059 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.11 | 27.76 | 1700 | 3331 | 0.5103 | 0.8144 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.11 | 27.76 | 2049 | 3331 | 0.6150 | 0.8641 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 41.11 | 27.76 | 2083 | 3331 | 0.6252 | 0.8685 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 42.81 | 27.76 | 1775 | 3596 | 0.4936 | 0.8086 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 42.81 | 27.76 | 1828 | 3596 | 0.5083 | 0.8162 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 42.81 | 27.76 | 2129 | 3596 | 0.5920 | 0.8560 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 42.81 | 27.76 | 2168 | 3596 | 0.6028 | 0.8608 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.52 | 27.76 | 1863 | 3884 | 0.4796 | 0.8041 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.52 | 27.76 | 1914 | 3884 | 0.4928 | 0.8110 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.52 | 27.76 | 2232 | 3884 | 0.5746 | 0.8504 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 44.52 | 27.76 | 2274 | 3884 | 0.5854 | 0.8553 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.22 | 27.76 | 1989 | 4125 | 0.4822 | 0.8077 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.22 | 27.76 | 2039 | 4125 | 0.4943 | 0.8139 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.22 | 27.76 | 2335 | 4125 | 0.5661 | 0.8483 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 46.22 | 27.76 | 2384 | 4125 | 0.5779 | 0.8537 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.93 | 27.76 | 2079 | 4421 | 0.4702 | 0.8040 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.93 | 27.76 | 2121 | 4421 | 0.4797 | 0.8089 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.93 | 27.76 | 2443 | 4421 | 0.5525 | 0.8442 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 47.93 | 27.76 | 2494 | 4421 | 0.5641 | 0.8494 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 49.63 | 27.76 | 2175 | 4818 | 0.4514 | 0.7972 | MN20160318_Q01 | D10 |